Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma
NCT00980382Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, docetaxel in gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Sep 2004; status: completed.
02
Drugs
tegafurdocetaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00980382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980382.